TA
ABBV icon

Tactive Advisors’s AbbVie ABBV Stock Holding History

Tactive Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$260K Buy
+993
New +$255K 0.06% 229
2024
Q1 		$342K Buy
+1,880
New +$324K 0.18% 91

Other funds holding ABBV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Tactive Advisors's ABBV Position: Q3 2026 in Review

Tactive Advisors opened a new position in AbbVie (ABBV) in Q3 2026: 993 shares worth $260K. The stake represents 0.06% of the portfolio and ranks #229 among its holdings. This is a return to the name: Tactive Advisors previously reported a position in ABBV as recently as Q1 2024.

Tactive Advisors first reported a position in ABBV in Q1 2024 and has held it in 2 quarters since. The position peaked at $342K in Q1 2024. 589 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Tactive Advisors held 993 shares of AbbVie worth $260K as of Q3 2026.
  • AbbVie was a new Tactive Advisors position in Q3 2026.
  • AbbVie made up 0.06% of Tactive Advisors's portfolio in Q3 2026, its #229 holding.
  • Tactive Advisors first reported a position in AbbVie in Q1 2024 and has held it in 2 quarters since.
  • Tactive Advisors's AbbVie position peaked at $342K in Q1 2024.
  • 589 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Tactive Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.